CSF biomarkers in the early diagnosis of mild cognitive impairment and Alzheimer's disease

V Papaliagkas, K Kalinderi, P Vareltzis… - International Journal of …, 2023 - mdpi.com
Alzheimer's disease (AD) is a rapidly growing disease that affects millions of people
worldwide, therefore there is an urgent need for its early diagnosis and treatment. A huge …

[HTML][HTML] Current biomarkers for Alzheimer's disease: from CSF to blood

K Zou, M Abdullah, M Michikawa - Journal of Personalized Medicine, 2020 - mdpi.com
Alzheimer's disease (AD) is the most common cause of dementia and affects a large portion
of the elderly population worldwide. Currently, a diagnosis of AD depends on the clinical …

The effects of curcumin on neurodegenerative diseases: A systematic review

RMF Bássoli, D Audi, BJ Ramalho, M Audi… - Journal of Herbal …, 2023 - Elsevier
ABSTRACT Introduction Neurodegenerative diseases (NDs) such as multiple sclerosis,
amyotrophic lateral sclerosis, Parkinson's disease, and Alzheimer's disease comprise a …

[HTML][HTML] Blood-Based Biomarkers in Alzheimer's Disease: Advancing Non-Invasive Diagnostics and Prognostics

M Dhauria, R Mondal, S Deb, G Shome… - International Journal of …, 2024 - mdpi.com
Alzheimer's disease (AD), the most prevalent form of dementia, is expected to rise
dramatically in incidence due to the global population aging. Traditional diagnostic …

A new generation of AD biomarkers: 2019 to 2021

J Hawksworth, E Fernández, K Gevaert - Ageing research reviews, 2022 - Elsevier
Alzheimer's disease (AD) is the most common form of dementia and cases are rising
worldwide. The effort to fight this disease is hampered by a lack of disease-modifying …

[HTML][HTML] Peripheral blood and cerebrospinal fluid levels of YKL-40 in Alzheimer's disease: a systematic review and Meta-analysis

Y Zhang, J Tian, J Ni, M Wei, T Li, J Shi - Brain Sciences, 2023 - mdpi.com
The pathogenesis associated with Alzheimer's disease (AD) is particularly complicated, and
early diagnosis and course monitoring of the disease are not ideal based on the available …

Demystifying the Role of Neuroinflammatory Mediators as Biomarkers for Diagnosis, Prognosis, and Treatment of Alzheimer's Disease: A Review

RR Doke, GJ Lamkhade, K Vinchurkar… - ACS Pharmacology & …, 2024 - ACS Publications
Neuroinflammatory mediators play a pivotal role in the pathogenesis of Alzheimer's Disease
(AD), influencing its onset, progression, and severity. The precise mechanisms behind AD …

Novel CSF biomarkers tracking autoimmune inflammatory and neurodegenerative aspects of CNS diseases

E Kapaki, AG Vakrakou, F Boufidou - Diagnostics, 2022 - mdpi.com
The accurate diagnosis of neuroinflammatory (NIDs) and neurodegenerative (NDDs)
diseases and the stratification of patients into disease subgroups with distinct disease …

Roles of microRNA-124 in traumatic brain injury: a comprehensive review

P Wu, B He, X Li, H Zhang - Frontiers in Cellular Neuroscience, 2023 - frontiersin.org
Traumatic brain injury (TBI) is a prominent global cause of mortality due to the limited
availability of effective prevention and treatment strategies for this disorder. An effective …